2Fukuoka M,Nitani H,Suzuki A.A phase Ⅱ study of CPT-11,a new derivative of camptothecin for previously untreated non-small cell lung cancer.J Clin Oncol,1992,10 (1):16 ～ 20.
3Rowinsky EK,Grochow LB,Hentricks CB,et al.Phase Ⅰ and pharmacologic study of topotecan:a novel topoisomerase Ⅰ inhibitor.J Clin Oncol,1992,10(4):647 ～656.
